Supplement × Prescription·a caution·Emerging evidence

Ginkgo Biloba + Levetiracetam Extended-Release

Caution Emerging evidence

Ginkgo has seizure case reports and may counter seizure control.

From the database

What the row says.

Every entry follows the same shape: what is happening, the mechanism, and the recommendation.

Pair type
Caution
Evidence
Emerging
Source citations
1
Scope
Supplement × Prescription
Last verified
June 4, 2026
CautionEmerging evidence

What is happening. Ginkgo has seizure case reports and may counter seizure control.

Mechanism. Potential seizure-threshold lowering can oppose antiseizure treatment.

Recommendation. Avoid ginkgo in epilepsy unless specifically approved by the neurologist.

Stack Score

How it moves the number.

Effect on the composite score

If both Ginkgo Biloba and Levetiracetam Extended-Release are in the same stack, this pair applies −5 to your Stack Score (per scored caution row).

The full algorithm, the clamping rules, and four worked stacks are at /methodology/stack-score.

Sources

Sources, by evidence tier.

Every claim on this page is cited. PMIDs link straight to PubMed.

Reference material

1
  • 1Lyseng-Williamson KA. Levetiracetam: a review of its use in epilepsy. Drugs. 2011.Needs sourceNo link

Check your full routine

One pair was the worked example.

Drop your supplements and prescriptions into NutriStack and it runs every pair at once: every interaction, synergy, timing rule, and contraindication, each linked to its primary source.

NutriStack is an informational and organizational tool, not a medical service, and not a substitute for professional advice. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or medication.